Hepatitis after liver transplantation: The role of the known and unknown viruses

被引:21
|
作者
Pessoa, MG
Terrault, NA
Ferrell, LD
Detmer, J
Kolberg, J
Collins, ML
Viele, M
Lake, JR
Roberts, JP
Ascher, NL
Wright, TL
机构
[1] Vet Affairs Med Ctr, Gastroenterol Unit, San Francisco, CA 94121 USA
[2] Dept Med, San Francisco, CA USA
[3] Dept Pathol, San Francisco, CA USA
[4] Dept Lab Med, San Francisco, CA USA
[5] Dept Surg, San Francisco, CA USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Chiron Corp, Emeryville, CA 94608 USA
来源
LIVER TRANSPLANTATION AND SURGERY | 1998年 / 4卷 / 06期
关键词
D O I
10.1002/lt.500040603
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This study was designed to determine the cause of posttransplantation hepatitis in patients undergoing transplantation for liver disease of nonviral cause; the Pole of acquired hepatitis B virus (HBV), hepatitis C Virus (HCV), and hepatitis G virus (HGV) in posttransplantation hepatitis; and the course of posttransplantation hepatitis of unknown cause, Two hundred forty-three patients underwent transplantation for nonviral liver diseases (mean age, 48 years; 103 men, 140 women). Serological and virological assays for HBV and HCV were performed pretransplantation to exclude preexisting infection and posttransplantation to investigate the cause of posttransplantation hepatitis. Histology was graded on all available biopsy specimens; posttransplantation hepatitis was assessable in 150 patients. Posttransplantation hepatitis was present in 29% (44 of 150) of the patients after a median follow-up of 47 months (range, 1 to 101 months). Actuarial survival was significantly lower in patients with posttransplantation hepatitis compared with patients without (71% v 89% at 5-year follow-up; P = .03), HCV and HBV were identified posttransplantation in 14% and 9% of patients with hepatitis, respectively. After the exclusion of HCV and HBV infection, 22% (33 of 150) of the patients had posttransplantation hepatitis of unknown cause, HGV was present in 58% of these patients, but HGV was equally prevalent in patients without posttransplantation hepatitis. When patients with HBV and HCV were excluded, there was no difference in survival between patients with posttransplantation hepatitis compared with patients without (P = .08, log-rank test). Posttransplantation hepatitis was present in approximately 30% of the patients undergoing transplantation for nonviral diseases, with a median follow-up of 47 months. Known hepatitis Viruses (HBV, HCV) were present in one fourth of the patients with posttransplantation hepatitis; 22% (33 of 150) of the patients had hepatitis of unknown cause, suggesting that other, as yet undiscovered, hepatitis Viruses may exist. (C) 1998 by the American Association for the Study of Liver Diseases.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 50 条
  • [1] Hepatitis viruses and liver transplantation
    Samuel, D
    Feray, C
    Bismuth, H
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S335 - S341
  • [2] LIVER-TRANSPLANTATION AND HEPATITIS VIRUSES
    WILLIAMS, R
    OGRADY, JG
    DAVIES, SE
    FAGAN, E
    [J]. ARCHIVES OF VIROLOGY, 1992, : 311 - 316
  • [3] Hepatitis B and hepatitis C viruses in liver transplantation
    Curry, MP
    [J]. TRANSPLANTATION, 2004, 78 (07) : 955 - 963
  • [4] The search for new hepatitis viruses in patients with post-liver transplantation hepatitis (post-OLTH) of unknown etiology
    Pessoa, MG
    Terrault, NA
    Ferrell, L
    Detmer, J
    Kolberg, J
    Wright, TL
    [J]. HEPATOLOGY, 1996, 24 (04) : 1144 - 1144
  • [5] THE ROLE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS OF UNKNOWN ETIOLOGY AFTER ORTHOTOPIC LIVER-TRANSPLANTATION (OLT)
    RAKELA, J
    POTERUCHA, JJ
    LUDWIG, J
    TASWELL, H
    KROM, RAF
    WIESNER, R
    [J]. HEPATOLOGY, 1990, 12 (04) : 1021 - 1021
  • [6] HEPATITIS-C ANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS OF UNKNOWN ETIOLOGY AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
    POTERUCHA, JJ
    RAKELA, J
    LUDWIG, J
    TASWELL, HF
    WIESNER, RH
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1495 - 1497
  • [7] Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation
    Hézode, C
    Duvoux, C
    Germanidis, G
    Roudot-Thoraval, F
    Vincens, AL
    Gaulard, P
    Cherqui, D
    Pawlotsky, JM
    Dhumeaux, D
    [J]. HEPATOLOGY, 1999, 30 (03) : 775 - 778
  • [8] Neuropsychiatric complications after liver transplantation: Role of immunosuppression and hepatitis C
    Tombazzi, Claudio R.
    Waters, Bradford
    Shokouh-Amiri, M. Hosein
    Vera, Santiago R.
    Riely, Caroline A.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (06) : 1079 - 1081
  • [9] The role of entecavir in preventing hepatitis B recurrence after liver transplantation
    Xi, Zhi Feng
    Xia, Qiang
    Zhang, Jian Jun
    Chen, Xiao Song
    Han, Long Zhi
    Wang, Xin
    Shen, Cong Huan
    Luo, Yi
    Xin, Tian Yu
    Wang, Si Yue
    Qiu, De Kai
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2009, 10 (04) : 321 - 327
  • [10] Neuropsychiatric Complications After Liver Transplantation: Role of Immunosuppression and Hepatitis C
    Claudio R. Tombazzi
    Bradford Waters
    M. Hosein Shokouh-Amiri
    Santiago R. Vera
    Caroline A. Riely
    [J]. Digestive Diseases and Sciences, 2006, 51 : 1079 - 1081